CMMB Stock Summary and Trading Ideas (Chemomab Therapeutics Ltd. - American Depositary Shares | NASDAQ:CMMB)

Chemomab Therapeutics Ltd is a clinical-stage biotechnology company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases.

Chemomab Therapeutics Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol CMMB.

As of September 21, 2026, CMMB stock price declined to $2.48 with 81,403 million shares trading.

CMMB has a beta of 1.78, meaning it tends to be more sensitive to market movements. CMMB has a correlation of 0.07 to the broad based SPY ETF.

CMMB has a market cap of $18.17 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, CMMB traded as high as $10.20 and as low as $1.35.

CMMB has underperformed the market in the last year with a price return of -5.7% while the SPY ETF gained +18.5%. However, in the short term, CMMB had mixed performance relative to the market. It has outperformed in the last 3 months, returning +63.2% vs +3.8% return in SPY. But in the last 2 weeks, CMMB shares have been beat by the market, returning -8.5% compared to an SPY return of +0.7%.

CMMB support price is $2.46 and resistance is $2.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMMB shares will trade within this expected range on the day.